The Mosaic Company ($MOS)

HR8374 is a structural policy bill introduced in the House that would remove statutory references to 'socially disadvantaged farmers and ranchers' from federal agriculture programs. The bill is in early legislative stages (referred to committee) with no clear path to passage, and no funding authorization or appropriation is involved. Direct market impact is negligible.

HR8457 (Homegrown Fertilizer Act) is an unfunded early-stage authorization bill with zero near-term market impact. It explicitly excludes CF Industries and Mosaic from eligibility. The bill remains in committee with no appropriation. $CF and $MOS recent price movements are driven by commodity fundamentals, not this legislation.

→ Mosaic is structurally ineligible for grants or loans. No revenue or cost impact from the bill. The bill does not impose new costs or regulations on Mosaic — it simply excludes incumbents from a subsidy program that has no appropriated funding.

HR7567 (Farm, Food, and National Security Act of 2026) passed the House Agriculture Committee 34-17 and is on the Union Calendar for floor debate. The bill reauthorizes USDA commodity, conservation, trade, and nutrition programs through FY2031. No specific dollar amounts are authorized in the bill text, but structural policy stability for 5 years removes downside risk for agribusiness equipment and input suppliers. Deere ($DE) at $590, ADM ($ADM) at $75.53, and CF Industries ($CF) at $125.08 are clear beneficiaries of maintained planted acreage. Mosaic ($MOS) at $23.52 faces headwinds from fertilizer price compression but benefits from volume stability.

→ Stable corn and soybean planted acreage (the two largest crops by U.S. acreage) supports consistent seasonal demand for crop nutrients; without a farm bill reauthorization risk, farmer deferral of fertilizer purchases due to policy uncertainty is reduced.

HR528 is an early-stage authorization bill introducing a federal post-disaster reforestation program on public lands. It has no appropriated funding, limited cosponsorship, and no material near-term market impact. The stock movements of exposed tickers ($WY, $LPX, $CF, $MOS) reflect broader sector trends, not legislative catalysts.

The Plant Biostimulant Act of 2025 (HR3783) defines biostimulants federally and exempts them from FIFRA pesticide registration, reducing regulatory costs for companies with biological product pipelines (FMC, NTR, MOS). The bill is in early legislative stages (referred to committee) with no authorized funding, limiting near-term market impact. Current stock prices reflect broader market trends rather than bill-specific catalysts: FMC at $15.61 (+4.91% over 7 days but -9.35% over 30), NTR at $75.15 (+5% 7-day), and MOS at $23.28 (-3% 7-day).

→ Reduces regulatory overlap for micronutrient products currently straddling fertilizer and pesticide definitions, lowering compliance costs and legal risk.

HR7716 (Tariff Free Farming Act) is an early-stage bill blocking new tariffs on imported agricultural inputs from normal trade relations countries. At referral stage with low near-term passage probability, its market impact is procedural. Fertilizer importers $NTR and downstream processors $ADM see a marginal bullish effect, while domestic producers $MOS and $CF lose a potential tariff-driven pricing tailwind.

→ By preserving tariff-free import status for foreign fertilizer from NTR countries, the bill removes the possibility that tariffs would raise import prices and create pricing power for domestic producers of phosphate and potash